What we do Galaxy Medicare Ltd manufactures and exports medical devices including Plaster of Paris bandages and surgical dressings, serving healthcare institutions in India and international markets. |
Founded in 1,992 |
Market share Established player in India's medical device manufacturing with export presence; engaged in government tenders through GEM portal. |
Problem solved Provides reliable wound care and medical dressing products essential for hospitals and clinics, improving patient care quality. |
Top clients or who we serve B2B focus serving government departments, hospitals, and international clients through exports. |
Key management - |
Our journey and innovations Evolved from acquiring a closed unit in 1992, partnered with global brands like '3M CAST', expanded product range to sterile surgical dressings since 2006. |
Where we operate India, Sri Lanka, Bangladesh, Nepal, and international export markets. |
Top products or what we offer Medical devices including POP Bandages, Elastic Adhesive Bandages, Sterile Gauze Dressings under brands like GYPSOPLAST, GYPSONET, and CAREPORE. |
Top brands GYPSOPLAST, GYPSONET, CAREPORE, fixcan - recognized brands in wound care category with institutional sales focus. |
Raw materials needed - |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mainly recurring from manufacturing and government tender supplies with export sales. |
Our industry position A reputed medical device producer with exclusive past partnerships and active tender participation maintaining steady market presence. |
Financial highlights FY2023-24 Revenue: Rs 39.2 crore; Net Profit: Rs 3.37 crore; IPO raised Rs 22.31 crore in 2025. |
Geographical revenue split - |
Order book - |
Whats driving growth Rising healthcare demand, institutional tenders, export market expansion, and trusted brand partnerships. |
Our future plans Expand manufacturing capabilities and strengthen export footprint following fresh capital infusion from IPO. |
Our green promise - |
Our people and values - |
Key challenges ahead Competition from larger multinational medical device firms and dependency on government tender cycles. |
Interesting facts First Indian partner for a UK brand 'GYPSONA' and long-term collaborator with Fortune 50 company 3M's Indian subsidiary. |
Risks and strategy Mitigate tender dependency risk by diversifying exports; focus on quality innovation to counter competition. |
